Primary Record
Valbenazine
- In stock
- 9,759 g
- Purity
- 99.2 %
- CAS
- 1025504-45-3
Compound Identifiers & Properties
- CAS
- 1025504-45-3
- PubChem CID
- 24795069
- SMILES
- CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC
- Canonical SMILES
- COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2
Names & Synonyms
- Valbenazine
- Ingrezza
- valbenazina
- valbenazinum
- 1025504-45-3
- Valbenazine [USAN]
- NBI-98854
- Valbenazine tosylate
- Valbenazine ditosylate
- Valbenazine [USAN:INN]
- RefChem:57014
- VALBENAZINE [MI]
- ValbenazineNBI-98854
- VALBENAZINE [INN]
- Valbenazine (USAN/INN)
- D0IX1I
- Mt-5199
- ValbenazineNBI-98854?
- UNII-54K37P50KH
- 54K37P50KH
- NBI 98854
- VALBENAZINE [WHO-DD]
- Valbenazine (~90% Purity)
- MFCD28963976
- DTXSID801026306
- GTPL8694
- orb1300029
- CHEMBL2364639
- SCHEMBL15932979
- SCHEMBL29361327
- N07XX13
- GEJDGVNQKABXKG-CFKGEZKQSA-N
- C24H38N2O4
- DTXCID301510540
- GLXC-10619
- EX-A2002
- BDBM50573733
- EBC-27029
- NBI-98782
- ZINC43195697
- AKOS027321089
- CS-5908
- DB11915
- NCGC00522306-02
- AC-30929
- AS-35294
- FV178689
- HY-16771
- NS00072536
- VMAT-2 inhibitor (CNS disease), Neurocrine
- J3.735.585B
- D10675
- EN300-7482951
- NBI-98854;NBI98854;NBI 98854
- A1008989
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester
- Q27089118
- B0084-474971
- [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate
- (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate
- (2R,3R,11bR)-9,10-Dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H- benzo(a)quinolizin-2-yl L-valinate
- (2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl (2S)-2-amino-3-methylbutanoate
- Vesicular monoamine transporter 2 inhibitor (CNS indications), Neurocrine
- ((2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-pyrido(2,1-a)isoquinolin-2-yl) (2S)-2-amino-3-methylbutanoate
- (2R,3R,11BR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-yl l-valinate
- (2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido(2,1-a)isoquinolin-2-yl (2S)-2-amino-3-methylbutanoate
- (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl ester
- [(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methyl-butanoate
- [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl] (2S)-2-amino-3-methylbutanoate
- L-Valine (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester
- L-Valine (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester; Ingrezza; NBI 98854; Valbenazine; (2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate
- L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester;L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester
- Valine 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester
- XW7